← Back to AIM

AIM ImmunoTech Inc. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 07/08/2026Sep 2025Filed 17/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 07/08/2026Sep 2024Filed 17/11/2025Jun 2024Filed 17/11/2025Mar 2024Filed 17/11/2025
$0$0$0$0$0$0$0.1$0
−$3.8−$3−$3.3−$2.8−$3.7−$3.7−$1.8−$5.8
−$0.43−$0.69$1.57−$3.68−$0.05−$6.00−$3.00−$0.12
174.42.10.849

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.